1 / 10

Antithrombotic Drugs Market | Global Industry Trends, Size, Share & Analysis 2018-26

Global Antithrombotic drugs market is anticipated to grow at a CAGR of 6.83% between 2018 and 2026. Request a free sample report now!

Download Presentation

Antithrombotic Drugs Market | Global Industry Trends, Size, Share & Analysis 2018-26

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GLOBAL ANTITHROMBOTIC DRUGS MARKET FORECAST2018-2026

  2. Globally, there has been a surge in the knee and hip replacement surgeries. Also, the NOACS are gaining increased adoption. • Propelled by these factors, the global Antithrombotic drugs market is anticipated to evolve further at a CAGR of 6.83% over the forecast period of 2018-2026.

  3. The antithrombotic drug market is segmented on the basis of anticoagulants, antiplatelet and thrombin inhibitors. • Over the coming years, factors like rising prevalence of coagulation disorders and healthcare and related industries are expected to grow continuously, which is anticipated to provide tremendous scope for the market to expand. • However, issues like patent expiration and lack of NOACS antidotes in the market are threatening the market progress.

  4. “The Global Antithrombotic drugs market is anticipated to grow at a CAGR of 6.83% between 2018 and 2026.”

  5. Some of the leading market players dealing in antithrombotic drugs market include Abbot Laboratories, ArmetheonInc, Baxter International, Bayer, BoehringerIngelheimGmbh, Bristol-Myers Squibb Co, Csl Behring, Daiichi Sankyo Co. Ltd, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Novartis, Pfizer, and Sanofi.

More Related